AU2000255631A1 - A synergistic anti-malarial formulation - Google Patents

A synergistic anti-malarial formulation

Info

Publication number
AU2000255631A1
AU2000255631A1 AU2000255631A AU5563100A AU2000255631A1 AU 2000255631 A1 AU2000255631 A1 AU 2000255631A1 AU 2000255631 A AU2000255631 A AU 2000255631A AU 5563100 A AU5563100 A AU 5563100A AU 2000255631 A1 AU2000255631 A1 AU 2000255631A1
Authority
AU
Australia
Prior art keywords
malarial
formulation
synergistic anti
synergistic
malarial formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000255631A
Inventor
Rajendra Singh Bhakuni
Sangeeta Dhawan
Guru Prakash Dutta
Anil Kumar Dwivedi
Dharm Chand Jain
Nuzhat Kamal
Suman Preeet Singh Khanuja
Sushil Kumar
Sudhanshu Saxena
Satyawan Singh
Renu Tripathi
Aseem Umesh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of AU2000255631A1 publication Critical patent/AU2000255631A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2000255631A 2000-03-31 2000-03-31 A synergistic anti-malarial formulation Abandoned AU2000255631A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2000/000039 WO2001074353A1 (en) 2000-03-31 2000-03-31 A synergistic anti-malarial formulation

Publications (1)

Publication Number Publication Date
AU2000255631A1 true AU2000255631A1 (en) 2001-10-15

Family

ID=11076239

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000255631A Abandoned AU2000255631A1 (en) 2000-03-31 2000-03-31 A synergistic anti-malarial formulation

Country Status (3)

Country Link
EP (1) EP1267864A1 (en)
AU (1) AU2000255631A1 (en)
WO (1) WO2001074353A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023897A1 (en) * 2001-11-13 2004-02-05 Caplan Michael J. Methods for preventing or treating disease mediated by toxin-secreting bacteria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0362810B1 (en) * 1988-10-07 1993-05-05 Hoechst Aktiengesellschaft Antimalarial compositions using quinidine, artemisinine and its derivatives
CN1058717A (en) * 1990-08-08 1992-02-19 中国人民解放军军事医学科学院微生物流行病研究所 New antimalarial agent-Coartem and preparation method thereof
CH692321A5 (en) * 1997-11-03 2002-05-15 Mepha Ag Pharmaceutically effective composition which comprises an effective anti-malarial parasite substance.
IN191696B (en) * 1999-02-12 2003-12-20 Council Scient Ind Res

Also Published As

Publication number Publication date
EP1267864A1 (en) 2003-01-02
WO2001074353A1 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU2002218250A1 (en) Medicament dispenser
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002242883A1 (en) Medicament dispenser
AU2002251238A1 (en) Medicament dispenser
AU2002358805A1 (en) Medicament dispenser
AU2001295657A1 (en) Formulation containing wax-esters
AU2002214284A1 (en) Anti-helicobacterial agents
AU2001266338A1 (en) Pharmaceutical compositions for angiogenic therapy
AU2002223562A1 (en) Medicament dispenser
AU2002222106A1 (en) Modular barrier
AU2001227535A1 (en) A core formulation
AU2001227532A1 (en) A core formulation
AU2002214324A1 (en) Medicinal compositions
AU2001266945A1 (en) Synergistic biocidal compositions
AU2001283344A1 (en) Dermatological formulation
AU2001273919A1 (en) Pharmaceutical compositions
AU2002236455A1 (en) Synergistic ecta compositions
AUPQ634300A0 (en) Synergistic formulations
AU4085201A (en) Pharmaceutical composition
AU2001272718A1 (en) Medicaments
AU2001233026A1 (en) Phosphodiesterases
AUPR099200A0 (en) New formulation
AU2002215902A1 (en) Medicament dispenser